RheumaGen

Denver, CO

RheumaGen is a gene-editing technology developing therapeutics to cure rheumatoid arthritis. It offers an HLA gene-editing platform that uses stem-cell-enriched blood to alter DNA to suppress the immune system and stop rheumatoid arthritis's abnormal immune response.

Company Details

Founded: 2019
Employees: Between 5 - 10 employees
Raised: $4,906,587
Headquarters Location: Denver, CO
Public: No
Acquired: No
Founders: Brian Hart

Company Collections

These are collections RheumaGen is a part of. Click on the collection name to view similar companies.

RheumaGen's Industries

Software Companies

Medical Organizations

Biotechnology Companies